Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Growth

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023
   Core EBITDA Growth(%) 96.50-

What is the latest Core EBITDA Growth ratio of GENPHARMASEC ?

The latest Core EBITDA Growth ratio of GENPHARMASEC is 96.50 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202496.50
Mar2023-

How is Core EBITDA Growth of GENPHARMASEC Trending?

Years Core EBITDA Growth % Change
Mar2024 96.5
0
Mar2023 0 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Growth ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹110.2 Cr 1.5% -1% -11.1% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹11,383.1 Cr 2% 17.6% 48.6% Stock Analytics
KIRI INDUSTRIES ₹3,205.6 Cr 0.7% 2.1% 58.5% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,961.6 Cr -5.2% -5.7% -14.7% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,128.4 Cr -4% 14.7% 51.9% Stock Analytics
BODAL CHEMICALS ₹859.4 Cr -9.4% -9.2% -13.6% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

1.5%

-1%

-11.1%

SENSEX

-1.2%

-3.5%

-0.5%


You may also like the below Video Courses